BlackRock’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-789,911
| Closed | -$1.18M | – | 5542 |
|
|
2023
Q1 | $1.18M | Sell |
789,911
-962
| -0.1% | -$1.44K | ﹤0.01% | 4197 |
|
|
2022
Q4 | $790K | Sell |
790,873
-234,839
| -23% | -$235K | ﹤0.01% | 4403 |
|
|
2022
Q3 | $1.85M | Sell |
1,025,712
-11,982
| -1% | -$21.6K | ﹤0.01% | 4144 |
|
|
2022
Q2 | $3.01M | Sell |
1,037,694
-1,495,222
| -59% | -$4.34M | ﹤0.01% | 3975 |
|
|
2022
Q1 | $6.99M | Buy |
2,532,916
+131,171
| +5% | +$362K | ﹤0.01% | 3699 |
|
|
2021
Q4 | $11.2M | Sell |
2,401,745
-562,900
| -19% | -$2.62M | ﹤0.01% | 3543 |
|
|
2021
Q3 | $25.2M | Buy |
2,964,645
+27,527
| +0.9% | +$234K | ﹤0.01% | 3080 |
|
|
2021
Q2 | $48.2M | Sell |
2,937,118
-129,518
| -4% | -$2.13M | ﹤0.01% | 2686 |
|
|
2021
Q1 | $67.7M | Buy |
3,066,636
+463,097
| +18% | +$10.2M | ﹤0.01% | 2389 |
|
|
2020
Q4 | $80.5M | Buy |
2,603,539
+496,950
| +24% | +$15.4M | ﹤0.01% | 2173 |
|
|
2020
Q3 | $42.8M | Buy |
2,106,589
+1,012,572
| +93% | +$20.6M | ﹤0.01% | 2338 |
|
|
2020
Q2 | $16.8M | Buy |
1,094,017
+200,089
| +22% | +$3.07M | ﹤0.01% | 2839 |
|
|
2020
Q1 | $6.92M | Buy |
893,928
+3,888
| +0.4% | +$30.1K | ﹤0.01% | 3132 |
|
|
2019
Q4 | $12.7M | Buy |
890,040
+60,221
| +7% | +$860K | ﹤0.01% | 3086 |
|
|
2019
Q3 | $12.5M | Buy |
829,819
+724,230
| +686% | +$10.9M | ﹤0.01% | 3075 |
|
|
2019
Q2 | $1.51M | Buy |
+105,589
| New | +$1.51M | ﹤0.01% | 3821 |
|